CLINICAL_TRIALS
ClinicalTrials.gov record with results posted
A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06109428
- Title field or adapter rule
- {'original_value': 'A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-29T01:00:17.534842+00:00
- Published At
- 2026-10-28T00:00:00+00:00
- Record Updated At
- 2026-10-28
- Results Posted At
- 2026-10-28
- Source Retrieved At
- 2026-10-29T01:00:16.864611+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Postoperative Pain", "Abdominoplasty Surgery", "Multimodal Analgesia"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT06109428"- protocolSection.identificationModule.officialTitle
"A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Bupivacaine HCl + MMA', 'HTX-011 + MMA'], 'description': 'acetaminophen 1 g every 8 hours (q8h) and ibuprofen 400 mg q8h, alternating the 2 medications so that an analgesic was taken approximately every 4 hours (q4h)', 'name': 'MMA regimen', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['HTX-011 + MMA'], 'description': 'ZYNRELEF kits include sterile, individually packaged components for administration, including vented vial spikes, Luer lock syringes, custom Luer lock applicators, and syringe tip caps.', 'name': 'ZYNRELEF kit components for administration', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['HTX-011 + MMA'], 'description': 'HTX-011 (bupivacaine/meloxicam) extended-release solution for instillation use, supplied in commercially available ZYNRELEF kits', 'name': 'HTX-011', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Bupivacaine HCl + MMA'], 'description': 'Bupivacaine HCl (without epinephrine) 0.25%', 'name': 'Bupivacaine Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
Drug names recorded in this source
A recorded drug name is not by itself an indication or a condition-specific relationship.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.